Scholar Rock (SRRK) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and Scholar Rock (NASDAQ:SRRK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

Is ASND or SRRK more profitable?

Scholar Rock has a net margin of 0.00% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat Scholar Rock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-54.94%	N/A	-24.31%
Scholar Rock	N/A	-127.11%	-90.09%

Do analysts rate ASND or SRRK?

Ascendis Pharma A/S presently has a consensus price target of $242.93, suggesting a potential upside of 26.81%. Scholar Rock has a consensus price target of $45.14, suggesting a potential upside of 38.82%. Given Scholar Rock's stronger consensus rating and higher possible upside, analysts plainly believe Scholar Rock is more favorable than Ascendis Pharma A/S.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00
Scholar Rock	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.22

Does the media refer more to ASND or SRRK?

In the previous week, Ascendis Pharma A/S had 9 more articles in the media than Scholar Rock. MarketBeat recorded 35 mentions for Ascendis Pharma A/S and 26 mentions for Scholar Rock. Ascendis Pharma A/S's average media sentiment score of 0.90 beat Scholar Rock's score of -0.11 indicating that Ascendis Pharma A/S is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	11 Very Positive mention(s)	2 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Scholar Rock	4 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	3 Very Negative mention(s)	Neutral

Which has more volatility and risk, ASND or SRRK?

Ascendis Pharma A/S has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Scholar Rock has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500.

Do institutionals & insiders have more ownership in ASND or SRRK?

91.1% of Scholar Rock shares are held by institutional investors. 40.0% of Ascendis Pharma A/S shares are held by company insiders. Comparatively, 13.3% of Scholar Rock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has higher valuation and earnings, ASND or SRRK?

Scholar Rock has lower revenue, but higher earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Scholar Rock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$393.54M	29.77	-$409.12M	-$5.16	-37.13
Scholar Rock	$33.19M	94.19	-$246.29M	-$2.91	-11.18

Summary

Scholar Rock beats Ascendis Pharma A/S on 10 of the 17 factors compared between the two stocks.